Evogene files annual report with SEC

Evogene, Ltd., a Rehovot, Israel-based company dedicated to the food, feed and biofuel industries as well as to the continued improvement of crop quality, said April 30 that it filed with the U.S. Securities and Exchange Commission (SEC) its annual report for the fiscal year ending Dec. 31, 2014.

The comprehensive report includes Evogene's audited, consolidated financial statements. It is available in its entirety on the SEC website at http://www.sec.gov/as or at Evogene's investor relations website, http://investors.evogene.com/financial-reports/report-2014.aspx.

Shareholders can request a hard copy of the report, which will be sent to them free of charge, by emailing karen.mazor@evogene.com.

Evogene "has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and abiotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease and nematodes), in key crops as corn, soybean, wheat and rice, and is also focused on the research and development of new products for crop protection (such as weed control)," Evogene said on its website.